Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated

Objective: To evaluate the long-term effect of botulinum toxin type A (BTX-A) in the treatment of HFS. Methods: A retrospective analysis of patients treated at the Movement Disorders Outpatient Clinic in the Neurology Service, Hospital de Clínicas, Federal University of Paraná, Curitiba, from 2009 to 2013 was carried out. A total of 550 BTX-A injections were administered to 100 HFS patients. Results: Mean duration of improvement following each injection session was 3.1 months, mean latency to detection of improvement was 7.1 days and mean success rate was 94.7%. Patients were evaluated at an interval of 5.8 months after each application. Adverse effects, which were mostly minor, were observed in 37% of the patients at least once during follow-up. The most frequent was ptosis (35.1%). Conclusion: Treatment of HFS with BTX-A was effective, sustainable and safe and had minimal, well-tolerated side effects.

Angaben zum Objekt

• Weitere Titel: Tratamento do espasmo hemi-facial com toxina botulínica tipo a foi efetivo, bem tolerado e com efeito sustentado
• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch

Verweise und Beziehungen

• Erschienen in: Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated ; volume:75 ; number:02 ; year:2017 ; pages:87-91 ; Arquivos de neuro-psiquiatria ; 75, Heft 02 (2017), 87-91

Beteiligte, Orts- und Zeitangaben

• Beteiligte Personen und Organisationen: Batisti, Jean Pierre Mette ; Kleinfelder, Alais Daiane Fadini ; Galli, Natália Bassalobre ; Moro, Adriana ; Munhoz, Renato Puppi ; Teive, Helio

Weitere Informationen

• DOI: 10.1590/0004-282X20160191
• URN: urn:nbn:de:101:1-2023101911131371892491
• Rechteinformation: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Letzte Aktualisierung: 14.08.2025, 10:50 MESZ